Latest Sai Life Sciences stock price
Sai Life Sciences P/E Ratio
SAILIFE • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
71.91
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
71.91
Current Price
₹923.30
EPS (TTM)
₹8.83
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
53.26
Sector Median
30.38
Sector Rank
#11 of 131
Sector Percentile
8.4%
Earnings Breakdown (TTM)
TTM EPS
₹13.37
Sept 2025
₹4.01
Mar 2025
₹4.24
Key P/E Ratio Insights for Sai Life Sciences
- Stock appears overvalued with PE of 71.91, suggesting caution for new investments
- Trading at premium to sector average PE of 53.26
View the SAILIFE equity price for detailed stock performance.
Related Pages for Sai Life Sciences
Additional stock information and data for SAILIFE
Sector P/E Ratio Comparison
Comparing Sai Life Sciences with other companies in Healthcare sector
Sector Average
53.26
Sector Median
30.38
Lowest P/E
1.5
Highest P/E
628.04
Companies
131
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.5 | ₹51 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 3.18 | ₹733 | Low |
| Murae Organisor | MURAE | 3.86 | ₹55 | Low |
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Zenith Drugs | ZENITHDRUG | 9.06 | ₹84 | Low |
| Galaxy Medicare | GML | 9.5 | ₹32 | Low |
| Balaxi Pharmaceuticals | BALAXI | 10.06 | ₹139 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Vasundhara Rasayans | VRL | 11.3 | ₹51 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |